Invitrogen and Emiliem Sign Major Kinase Screening Agreement
CARLSBAD & EMERYVILLE, California -- Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, today announced a partnership with Emiliem, Inc. to screen the company's multi- …